{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T10:05:46Z","timestamp":1750327546976,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001784","name":"Victoria University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00424-020-02480-4","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:04:20Z","timestamp":1603112660000},"page":"107-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Platinum accumulation in the brain and alteration in the central regulation of cardiovascular and respiratory functions in oxaliplatin-treated rats"],"prefix":"10.1007","volume":"473","author":[{"given":"Ahmed A.","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Stojanovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Pilowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-6929","authenticated-orcid":false,"given":"Kulmira","family":"Nurgali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"2480_CR1","doi-asserted-by":"publisher","first-page":"R1019","DOI":"10.1152\/ajpregu.90885.2008","volume":"296","author":"SB Abbott","year":"2009","unstructured":"Abbott SB, Pilowsky PM (2009) Galanin microinjection into rostral ventrolateral medulla of the rat is hypotensive and attenuates sympathetic chemoreflex. Am J Physiol Regul Integr Comp Physiol 296:R1019\u2013R1026. https:\/\/doi.org\/10.1152\/ajpregu.90885.2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2480_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12885-015-1418-3","volume":"15","author":"SC Adams","year":"2015","unstructured":"Adams SC, Schondorf R, Benoit J, Kilgour RD (2015) Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study. BMC Cancer 15:414. https:\/\/doi.org\/10.1186\/s12885-015-1418-3","journal-title":"BMC Cancer"},{"key":"2480_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-2999(00)00667-1","volume":"406","author":"H Adelsberger","year":"2000","unstructured":"Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C (2000) The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol 406:25\u201332","journal-title":"Eur J Pharmacol"},{"key":"2480_CR4","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","volume":"37","author":"G Cavaletti","year":"2001","unstructured":"Cavaletti G, Tredici G, Petruccioli MG, Donde E, Tredici P, Marmiroli P, Minoia C, Ronchi A, Bayssas M, Etienne GG (2001) Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer 37:2457\u20132463","journal-title":"Eur J Cancer"},{"key":"2480_CR5","doi-asserted-by":"publisher","unstructured":"Dampney RAL (2017) Resetting of the baroreflex control of sympathetic vasomotor activity during natural behaviors: description and conceptual model of central mechanisms. Front Neurosci 11. https:\/\/doi.org\/10.3389\/fnins.2017.00461","DOI":"10.3389\/fnins.2017.00461"},{"key":"2480_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/ene.12514","volume":"21","author":"EV Dermitzakis","year":"2014","unstructured":"Dermitzakis EV, Kimiskidis VK, Eleftheraki A, Lazaridis G, Konstantis A, Basdanis G, Tsiptsios I, Georgiadis G, Fountzilas G (2014) The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system. Eur J Neurol 21:1471\u20131477. https:\/\/doi.org\/10.1111\/ene.12514","journal-title":"Eur J Neurol"},{"key":"2480_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","volume":"13","author":"ML Di Cesare","year":"2012","unstructured":"Di Cesare ML, Zanardelli M, Failli P, Ghelardini C (2012) Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain 13:276\u2013284. https:\/\/doi.org\/10.1016\/j.jpain.2011.11.009","journal-title":"J Pain"},{"key":"2480_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejphar.2010.09.085","volume":"650","author":"ESE El-Awady","year":"2011","unstructured":"El-Awady ESE, Moustafa YM, Abo-Elmatty DM, Radwan A (2011) Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol 650:335\u2013341. https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.085","journal-title":"Eur J Pharmacol"},{"key":"2480_CR9","unstructured":"Eloxatin (2014) Product monograph. http:\/\/products.sanofi.ca\/en\/eloxatin.pdf. (accessed 2\/2014)"},{"key":"2480_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jat\/32.2.140","volume":"32","author":"D Esteban-Fernandez","year":"2008","unstructured":"Esteban-Fernandez D, Verdaguer JM, Ramirez-Camacho R, Palacios MA, Gomez-Gomez MM (2008) Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration. J Anal Toxicol 32:140\u2013146","journal-title":"J Anal Toxicol"},{"key":"2480_CR11","first-page":"13","volume":"25","author":"JM Extra","year":"1998","unstructured":"Extra JM, Marty M, Brienza S, Misset JL (1998) Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol 25:13\u201322","journal-title":"Semin Oncol"},{"key":"2480_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2011.02.066","volume":"1386","author":"AR Fathi","year":"2011","unstructured":"Fathi AR, Yang C, Bakhtian KD, Qi M, Lonser RR, Pluta RM (2011) Carbon dioxide influence on nitric oxide production in endothelial cells and astrocytes: cellular mechanisms. Brain Res 1386:50\u201357. https:\/\/doi.org\/10.1016\/j.brainres.2011.02.066","journal-title":"Brain Res"},{"key":"2480_CR13","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.1200\/jco.2005.08.789","volume":"23","author":"JD Floyd","year":"2005","unstructured":"Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC (2005) Cardiotoxicity of cancer therapy. J Clin Oncol 23:7685\u20137696. https:\/\/doi.org\/10.1200\/jco.2005.08.789","journal-title":"J Clin Oncol"},{"key":"2480_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/sonc.2002.35525","volume":"29","author":"E Gamelin","year":"2002","unstructured":"Gamelin E, Gamelin L, Bossi L, Quasthoff S (2002) Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 29:21\u201333. https:\/\/doi.org\/10.1053\/sonc.2002.35525","journal-title":"Semin Oncol"},{"key":"2480_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2014.10.017","volume":"263","author":"PS Garry","year":"2015","unstructured":"Garry PS, Ezra M, Rowland MJ, Westbrook J, Pattinson KT (2015) The role of the nitric oxide pathway in brain injury and its treatment--from bench to bedside. Exp Neurol 263:235\u2013243. https:\/\/doi.org\/10.1016\/j.expneurol.2014.10.017","journal-title":"Exp Neurol"},{"key":"2480_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/01.hyp.31.1.68","volume":"31","author":"G Grassi","year":"1998","unstructured":"Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G (1998) Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31:68\u201372. https:\/\/doi.org\/10.1161\/01.hyp.31.1.68","journal-title":"Hypertension"},{"key":"2480_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1200\/jco.1992.10.5.795","volume":"10","author":"RW Gregg","year":"1992","unstructured":"Gregg RW, Molepo JM, Monpetit VJ, Mikael NZ, Redmond D, Gadia M, Stewart DJ (1992) Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 10:795\u2013803. https:\/\/doi.org\/10.1200\/jco.1992.10.5.795","journal-title":"J Clin Oncol"},{"key":"2480_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1743-7563.2012.01547.x","volume":"8","author":"C Han","year":"2012","unstructured":"Han C, McKeage M (2012) Neuropathies associated with oxaliplatin therapy. Asia Pac J Clin Oncol 8:107\u2013110. https:\/\/doi.org\/10.1111\/j.1743-7563.2012.01547.x","journal-title":"Asia Pac J Clin Oncol"},{"key":"2480_CR19","doi-asserted-by":"publisher","first-page":"iii-ix","DOI":"10.3310\/hta12150","volume":"12","author":"D Hind","year":"2008","unstructured":"Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A (2008) The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess 12:iii-ix\u2013xi-162","journal-title":"Health Technol Assess"},{"key":"2480_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000169528","volume":"57","author":"BB Kent","year":"1972","unstructured":"Kent BB, Drane JW, Blumenstein B, Manning JW (1972) A mathematical model to assess changes in the baroreceptor reflex. Cardiology 57:295\u2013310","journal-title":"Cardiology"},{"key":"2480_CR21","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/01.CIR.0000017186.52382.F4","volume":"105","author":"T Ketch","year":"2002","unstructured":"Ketch T, Biaggioni I, Robertson R, Robertson D (2002) Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation 105:2518\u20132523","journal-title":"Circulation"},{"key":"2480_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/01.RES.43.2.170","volume":"43","author":"G Mancia","year":"1978","unstructured":"Mancia G, Ludbrook J, Ferrari A, Gregorini L, Zanchetti A (1978) Baroreceptor reflexes in human hypertension. Circ Res 43:170\u2013177. https:\/\/doi.org\/10.1161\/01.RES.43.2.170","journal-title":"Circ Res"},{"key":"2480_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2004.09.013","volume":"18","author":"ES McDonald","year":"2005","unstructured":"McDonald ES, Randon KR, Knight A, Windebank AJ (2005) Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol Dis 18:305\u2013313. https:\/\/doi.org\/10.1016\/j.nbd.2004.09.013","journal-title":"Neurobiol Dis"},{"key":"2480_CR24","doi-asserted-by":"publisher","first-page":"H2003","DOI":"10.1152\/ajpheart.00219.2006","volume":"291","author":"LM McDowall","year":"2006","unstructured":"McDowall LM, Dampney RA (2006) Calculation of threshold and saturation points of sigmoidal baroreflex function curves. Am J Phys Heart Circ Phys 291:H2003\u2013H2007. https:\/\/doi.org\/10.1152\/ajpheart.00219.2006","journal-title":"Am J Phys Heart Circ Phys"},{"key":"2480_CR25","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1111\/bph.13646","volume":"173","author":"RM McQuade","year":"2016","unstructured":"McQuade RM, Carbone SE, Stojanovska V, Rahman A, Gwynne RM, Robinson AM, Goodman CA, Bornstein JC, Nurgali K (2016) Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice. Br J Pharmacol 173:3502\u20133521. https:\/\/doi.org\/10.1111\/bph.13646","journal-title":"Br J Pharmacol"},{"key":"2480_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijcard.2010.03.003","volume":"144","author":"JJ Monsuez","year":"2010","unstructured":"Monsuez JJ, Charniot JC, Vignat N, Artigou JY (2010) Cardiac side-effects of cancer chemotherapy. Int J Cardiol 144:3\u201315. https:\/\/doi.org\/10.1016\/j.ijcard.2010.03.003","journal-title":"Int J Cardiol"},{"key":"2480_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.hyp.32.6.1039","volume":"32","author":"K Narkiewicz","year":"1998","unstructured":"Narkiewicz K, Pesek CA, Kato M, Phillips BG, Davison DE, Somers VK (1998) Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 32:1039\u20131043. https:\/\/doi.org\/10.1161\/01.hyp.32.6.1039","journal-title":"Hypertension"},{"key":"2480_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/01.CIR.100.3.262","volume":"100","author":"K Narkiewicz","year":"1999","unstructured":"Narkiewicz K, Pesek CA, van de Borne PJ, Kato M, Somers VK (1999) Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100:262\u2013267","journal-title":"Circulation"},{"key":"2480_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.neuroscience.2016.01.012","volume":"317","author":"PE Nedoboy","year":"2016","unstructured":"Nedoboy PE, Mohammed S, Kapoor K, Bhandare AM, Farnham MM, Pilowsky PM (2016) pSer40 tyrosine hydroxylase immunohistochemistry identifies the anatomical location of C1 neurons in rat RVLM that are activated by hypotension. Neuroscience 317:162\u2013172. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.012","journal-title":"Neuroscience"},{"key":"2480_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1476-5381.2011.01436.x","volume":"164","author":"AA Rahman","year":"2011","unstructured":"Rahman AA, Shahid IZ, Pilowsky PM (2011) Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat. Br J Pharmacol 164:617\u2013631","journal-title":"Br J Pharmacol"},{"key":"2480_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1124\/jpet.111.191254","volume":"341","author":"AA Rahman","year":"2012","unstructured":"Rahman AA, Shahid IZ, Pilowsky PM (2012) Differential cardiorespiratory and sympathetic reflex responses to microinjection of neuromedin U in rat rostral ventrolateral medulla. J Pharmacol Exp Ther 341:213\u2013224","journal-title":"J Pharmacol Exp Ther"},{"key":"2480_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.peptides.2013.03.017","volume":"44","author":"AA Rahman","year":"2013","unstructured":"Rahman AA, Shahid IZ, Pilowsky PM (2013) Neuromedin U causes biphasic cardiovascular effects and impairs baroreflex function in rostral ventrolateral medulla of spontaneously hypertensive rat. Peptides 44:15\u201324. https:\/\/doi.org\/10.1016\/j.peptides.2013.03.017","journal-title":"Peptides"},{"key":"2480_CR33","first-page":"4","volume":"25","author":"E Raymond","year":"1998","unstructured":"Raymond E, Faivre S, Woynarowski JM, Chaney SG (1998) Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 25:4\u201312","journal-title":"Semin Oncol"},{"key":"2480_CR34","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/01.CIR.82.3.856","volume":"82","author":"RF Rea","year":"1990","unstructured":"Rea RF, Hamdan M (1990) Baroreflex control of muscle sympathetic nerve activity in borderline hypertension. Circulation 82:856\u2013862. https:\/\/doi.org\/10.1161\/01.CIR.82.3.856","journal-title":"Circulation"},{"key":"2480_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB J"},{"key":"2480_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1744-8069-7-29","volume":"7","author":"CL Renn","year":"2011","unstructured":"Renn CL, Carozzi VA, Rhee P, Gallop D, Dorsey SG, Cavaletti G (2011) Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol Pain 7:29. https:\/\/doi.org\/10.1186\/1744-8069-7-29","journal-title":"Mol Pain"},{"key":"2480_CR37","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1200\/jco.2003.11.126","volume":"21","author":"ML Rothenberg","year":"2003","unstructured":"Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK, Hart LL, Gupta S, Garay CA, Burger BG, Le Bail N, Haller DG (2003) Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21:2059\u20132069. https:\/\/doi.org\/10.1200\/jco.2003.11.126","journal-title":"J Clin Oncol"},{"key":"2480_CR38","first-page":"249","volume":"1","author":"MW Saif","year":"2005","unstructured":"Saif MW, Reardon J (2005) Management of oxaliplatin-induced peripheral neuropathy. Ther Clin Risk Manag 1:249\u2013258","journal-title":"Ther Clin Risk Manag"},{"key":"2480_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bjc.1997.416","volume":"76","author":"D Screnci","year":"1997","unstructured":"Screnci D, Er HM, Hambley TW, Galettis P, Brouwer W, McKeage MJ (1997) Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin. Br J Cancer 76:502\u2013510","journal-title":"Br J Cancer"},{"key":"2480_CR40","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1054\/bjoc.1999.1026","volume":"82","author":"D Screnci","year":"2000","unstructured":"Screnci D, McKeage MJ, Galettis P, Hambley TW, Palmer BD, Baguley BC (2000) Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer 82:966\u2013972. https:\/\/doi.org\/10.1054\/bjoc.1999.1026","journal-title":"Br J Cancer"},{"key":"2480_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ctrv.2010.11.001","volume":"37","author":"E Senkus","year":"2011","unstructured":"Senkus E, Jassem J (2011) Cardiovascular effects of systemic cancer treatment. Cancer Treat Rev 37:300\u2013311. https:\/\/doi.org\/10.1016\/j.ctrv.2010.11.001","journal-title":"Cancer Treat Rev"},{"key":"2480_CR42","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1111\/j.1476-5381.2011.01694.x","volume":"165","author":"IZ Shahid","year":"2012","unstructured":"Shahid IZ, Rahman AA, Pilowsky PM (2012) Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex. Br J Pharmacol 165:2292\u20132303","journal-title":"Br J Pharmacol"},{"key":"2480_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3816\/CCC.2009.n.038","volume":"8","author":"JH Slade","year":"2009","unstructured":"Slade JH, Alattar ML, Fogelman DR, Overman MJ, Agarwal A, Maru DM, Coulson RL, Charnsangavej C, Vauthey JN, Wolff RA, Kopetz S (2009) Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 8:225\u2013230. https:\/\/doi.org\/10.3816\/CCC.2009.n.038","journal-title":"Clin Colorectal Cancer"},{"key":"2480_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fphar.2017.00137","volume":"8","author":"JC Sorensen","year":"2017","unstructured":"Sorensen JC, Petersen AC, Timpani CA, Campelj DG, Cook J, Trewin AJ, Stojanovska V, Stewart M, Hayes A, Rybalka E (2017) BGP-15 protects against oxaliplatin-induced skeletal myopathy and mitochondrial reactive oxygen species production in mice. Front Pharmacol 8:137. https:\/\/doi.org\/10.3389\/fphar.2017.00137","journal-title":"Front Pharmacol"},{"key":"2480_CR45","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","volume":"27","author":"LE Ta","year":"2006","unstructured":"Ta LE, Espeset L, Podratz J, Windebank AJ (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27:992\u20131002. https:\/\/doi.org\/10.1016\/j.neuro.2006.04.010","journal-title":"Neurotoxicology"},{"key":"2480_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.autneu.2005.12.006","volume":"128","author":"M Uchino","year":"2006","unstructured":"Uchino M, Kuwahara M, Ebukuro S, Tsubone H (2006) Modulation of emetic response by carotid baro- and chemoreceptor activations. Auton Neurosci 128:25\u201336. https:\/\/doi.org\/10.1016\/j.autneu.2005.12.006","journal-title":"Auton Neurosci"},{"key":"2480_CR47","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.cir.0000133187.74800.b9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109:3122\u20133131. https:\/\/doi.org\/10.1161\/01.cir.0000133187.74800.b9","journal-title":"Circulation"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-020-02480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-020-02480-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-020-02480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T06:04:08Z","timestamp":1634623448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-020-02480-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s00424-020-02480-4","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"type":"print","value":"0031-6768"},{"type":"electronic","value":"1432-2013"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"9 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}